It has been confirmed that tumor-derived IL-8 can promote tumor angiogenesis, recruit MDSCs to suppress anti-tumor immune responses (Figure 5) and maintain the epithelial mesenchymal transition phenotype of tumor cells, thereby participating in the proliferation and metastasis of tumor cells (107–110). Here, CXCL8 is linked to neoplasm.